Literature DB >> 2518651

ACE inhibitors compared with thiazide diuretics as first-step antihypertensive therapy.

I J Perry1, D G Beevers.   

Abstract

While ACE inhibitors are considerably more expensive than thiazide diuretics, they are slightly more effective antihypertensive agents in white patients and have fewer side effects. They can be regarded as suitable first-line therapy in diabetic hypertensives. It is probable that as new drugs in this class are marketed, the price differential will lessen and they will be regarded as acceptable and useful first-line drugs in an increasingly large number of patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2518651     DOI: 10.1007/bf01869564

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  25 in total

1.  A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension.

Authors:  M S Kochar; G Bolek; J H Kalbfleisch; P Olzinski
Journal:  J Clin Pharmacol       Date:  1987 May-Jun       Impact factor: 3.126

2.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors:  E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.

Authors:  J L Pool; J Gennari; R Goldstein; M S Kochar; A J Lewin; M H Maxwell; J A McChesney; J Mehta; D T Nash; E B Nelson
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 4.  The cardiovascular risks of thiazide diuretics.

Authors:  E D Freis
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

5.  Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study.

Authors:  S Vardan; K G Mehrotra; S Mookherjee; G A Willsey; J D Gens; D E Green
Journal:  JAMA       Date:  1987 Jul 24-31       Impact factor: 56.272

6.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

7.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

8.  Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension.

Authors:  J G Gums; L M Lopez; G P Quay; G H Stein; D L McCarley
Journal:  Drug Intell Clin Pharm       Date:  1988-09

9.  Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.

Authors:  W H Frishman; J Goldberger; D Sherman
Journal:  J Clin Hypertens       Date:  1987-12       Impact factor: 3.738

10.  Enalapril and hydrochlorothiazide as antihypertensive agents in the elderly.

Authors:  D A Shapiro; C L Liss; J F Walker; J L Lewis; R A Lengerich; J D Irvin
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.